DFDA

Levothyroxine

Treatment for Hashimotos Thyroiditis

Typical Dosage: 25-300 mcg daily

Effectiveness
90%
Safety Score
65%
Clinical Trials
11
Participants
5M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
25-300 mcg daily
Time to Effect
4-8 weeks
Treatment Duration
lifetime
Evidence Quality
HIGH
Confidence Score
98%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30
Monitoring:$200
Side Effect Mgmt:$50
Total Annual:$280
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
1.2
Outcome-Based Costs
Cost per Responder
$295
Cost per Remission
$295
Comparison vs No treatment (for overt hypothyroidism)
Cost Difference
$-1,000/year
Less expensive
QALY Difference
+1.50 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Prescription Access Economics
Levothyroxine Outcomes

for Hashimotos Thyroiditis

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+95%
Remission Rate
+95%
Common Side Effects
Hyperthyroid symptoms (e.g., palpitations, anxiety, weight loss)
+10%
Allergic reactions (rare)
+0.1%

Sources:

researchgate.net
ijsra.net
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Levothyroxine in Hashimotos Thyroiditis

Hashimoto - a Surgical Disease. Total Thyroidectomy Makes Antibodies Disappear and Ameliorates Symptoms

NCT02319538COMPLETEDNA
View Study
150 participants
INTERVENTIONAL
Skien, Norway
Started: Feb 13, 2012